Turnstone Biologics Shares Owned By Institutions vs. Book Value Per Share
TSBX Stock | 0.48 0.02 4.00% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 1.03 | 0.855 |
|
|
For Turnstone Biologics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Turnstone Biologics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Turnstone Biologics Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Turnstone Biologics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Turnstone Biologics Corp over time as well as its relative position and ranking within its peers.
Turnstone |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Turnstone Biologics. If investors know Turnstone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Turnstone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.23) | Quarterly Revenue Growth (1.00) | Return On Assets (0.66) | Return On Equity (1.34) |
The market value of Turnstone Biologics Corp is measured differently than its book value, which is the value of Turnstone that is recorded on the company's balance sheet. Investors also form their own opinion of Turnstone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Turnstone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Turnstone Biologics' market value can be influenced by many factors that don't directly affect Turnstone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Turnstone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Turnstone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Turnstone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Turnstone Biologics Corp Book Value Per Share vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Turnstone Biologics's current stock value. Our valuation model uses many indicators to compare Turnstone Biologics value to that of its competitors to determine the firm's financial worth. Turnstone Biologics Corp is currently regarded as top stock in shares owned by institutions category among its peers. It also is currently regarded as top stock in book value per share category among its peers creating about 0.04 of Book Value Per Share per Shares Owned By Institutions. The ratio of Shares Owned By Institutions to Book Value Per Share for Turnstone Biologics Corp is roughly 25.41 . At this time, Turnstone Biologics' Book Value Per Share is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Turnstone Biologics' earnings, one of the primary drivers of an investment's value.Turnstone Book Value Per Share vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Turnstone Biologics |
| = | 65.64 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Turnstone Biologics |
| = | 2.58 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Turnstone Book Value Per Share Comparison
Turnstone Biologics is currently under evaluation in book value per share category among its peers.
Turnstone Biologics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Turnstone Biologics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Turnstone Biologics will eventually generate negative long term returns. The profitability progress is the general direction of Turnstone Biologics' change in net profit over the period of time. It can combine multiple indicators of Turnstone Biologics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Accumulated Other Comprehensive Income | -119 K | -125 K | |
Operating Income | -59 M | -56.1 M | |
Net Loss | -52.4 M | -49.8 M | |
Income Before Tax | -55.5 M | -52.7 M | |
Total Other Income Expense Net | 3.5 M | 1.9 M | |
Net Loss | -27.9 M | -26.5 M | |
Net Loss | -55.2 M | -52.4 M | |
Income Tax Expense | -286 K | -271.7 K | |
Change To Netincome | 15.9 M | 10.6 M | |
Net Loss | (4.77) | (4.54) | |
Income Quality | 1.20 | 1.26 | |
Net Income Per E B T | 0.99 | 0.80 |
Turnstone Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Turnstone Biologics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Turnstone Biologics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Turnstone Biologics' important profitability drivers and their relationship over time.
Use Turnstone Biologics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Turnstone Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Turnstone Biologics will appreciate offsetting losses from the drop in the long position's value.Turnstone Biologics Pair Trading
Turnstone Biologics Corp Pair Trading Analysis
The ability to find closely correlated positions to Turnstone Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Turnstone Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Turnstone Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Turnstone Biologics Corp to buy it.
The correlation of Turnstone Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Turnstone Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Turnstone Biologics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Turnstone Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Turnstone Biologics position
In addition to having Turnstone Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All Next | Launch |
Additional Tools for Turnstone Stock Analysis
When running Turnstone Biologics' price analysis, check to measure Turnstone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Turnstone Biologics is operating at the current time. Most of Turnstone Biologics' value examination focuses on studying past and present price action to predict the probability of Turnstone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Turnstone Biologics' price. Additionally, you may evaluate how the addition of Turnstone Biologics to your portfolios can decrease your overall portfolio volatility.